نتائج البحث 11-20 من 5947 لعملية البحث عن Assay
The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. MC230818 ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. AZD0486 As Monotherapy In Participants ...
The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. A Pilot ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. ... assays and results from a ctDNA assay by ...
... assay. A database of paired clinical and sequencing data will also be established for future research. Gynecologic Extramammary Paget's Disease. Rochester ...
The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...
The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.